Biography: 

Dr. Benjamin Freedman has studied the cell and systems biology of vertebrate stem cells for over twenty years. He is known for directing differentiation of iPS cells into human kidney organoids to establish ‘disease in a dish’ models of polycystic kidney disease, glomerulosclerosis, and other disorders. He has further shown the ability of transplanted kidney organoids to engraft in vivo as a step towards regenerative medicine.

He has received numerous honors and awards, including the 2018 Stem Cells Young Investigator Award, the 2023 Donald W. Seldin American Society of Nephrology Young Investigator Award, and the 2025 NIH TARGETED Prize for the Somatic Cell Genome Editing. He is currently an Associate Professor of Medicine at the University of Washington, where his group combines cell biology, medicine, and bioengineering to understand mechanisms of disease and develop therapies.

Highlighted Links:

Contact

Publications